Skip to main content
. 2017 Mar 6;38(4):581–590. doi: 10.1038/aps.2016.164

Table 2. Association between lncRNA polymorphisms and platinum-based chemotherapy toxicity.

Type of toxicity Gene SNP Genotype Grade 0–2 n (%) Grade 3–4 n (%) Additive
Dominant
Recessive
            OR (95% CI) P OR (95% CI) P OR (95% CI) P
Overall toxicity ANRIL rs1333049 GG 69 (24.3) 32 (17.8) 0.723 (0.541, 0.965) 0.028* 0.662 (0.424, 1.035) 0.070 0.649 (0.399, 1.054) 0.080
      GC 152 (53.5) 97 (53.9)            
      CC 63 (22.2) 51 (28.3)            
Gastrointestinal toxicity ANRIL rs1333049 GG 83 (22.9) 18 (17.8) 0.690 (0.489, 0.974) 0.035* 0.558 (0.335, 0.931) 0.025* 0.711 (0.396, 1.276) 0.252
      GC 198 (54.5) 51 (50.5)            
      CC 82 (22.6) 32 (31.7)            
  MEG3 rs116907618 CC 1 (0.3) 2 (1.9) 1.717 (1.007, 2.927) 0.047* 1.678 (0.941, 2.992) 0.080 6.149 (0.540, 70.060) 0.143
      CG 51 (13.9) 20 (19.8)            
      GG 314 (85.8) 79 (78.2)            

Abbreviations: SNP, single nucleotide polymorphism; n, number; OR, odd ratio; CI, confidence interval.

*P<0.05.